InsidersTradesSigma
Follow the EMR stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Market capitalisation: €4.2bn. The latest transaction was filed on 5 June 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is free.
Analysts rate EMR Buy (bullish), based on 3 analysts. Average price target: A$7.43.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
EMR 是一家在 XASX 上市的公司，专注于金融领域。